Suppr超能文献

82 例成人史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的病因和治疗结果。

Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients.

机构信息

Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea.

出版信息

Korean J Intern Med. 2012 Jun;27(2):203-10. doi: 10.3904/kjim.2012.27.2.203. Epub 2012 May 31.

Abstract

BACKGROUND/AIMS: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are predominantly known as medication-induced diseases. However, at our institution, we have experienced more cases of non-drug-related SJS and TEN than expected. Therefore, we studied the difference between non-drug-related and drug-related SJS and TEN in terms of clinical characteristics and prognoses.

METHODS

The etiologies, clinical characteristics, and treatment outcomes for 82 adult patients with SJS and TEN were retrospectively reviewed.

RESULTS

A total of 71 patients (86.6%) were classified as having SJS, and the other 11 patients (13.4%) were classified as having TEN. Drug-related cases were more common (43, 52.4%) than non-drug-related cases (39, 47.6%). Anticonvulsants (12/82, 14.6%) and antibiotics (9/82, 11%) were the most common causative medications. Anemia (p = 0.017) and C-reactive protein of ≥ 5 mg/dL (p = 0.026) were more common in the drug-related cases than in the non-drug-related cases. Intravenous steroid therapy was used as the main treatment regimen (70/82, 85.4%). Of the 82 patients, 8 (9.8%) died during the clinical course. A univariate analysis for mortality showed statistical significance for the following: kidney function abnormality, pneumonia, hemoglobin of < 10 g/dL, and combined underlying diseases. In a multivariate analysis, only pneumonia was statistically significant (odds ratio, 25.79; p = 0.009).

CONCLUSIONS

Drugs were the most frequent cause of these diseases. However, non-drug-related causes also contributed to a significant proportion of cases. Physicians should keep this in mind when documenting patient history. In addition, early recognition and treatment may be important for better outcomes.

摘要

背景/目的:史蒂文斯-约翰逊综合征(SJS)和中毒性表皮坏死松解症(TEN)主要被认为是药物引起的疾病。然而,在我们的机构中,我们遇到的非药物相关的 SJS 和 TEN 病例比预期的要多。因此,我们研究了非药物相关和药物相关的 SJS 和 TEN 在临床特征和预后方面的差异。

方法

回顾性分析了 82 例成人 SJS 和 TEN 患者的病因、临床特征和治疗结果。

结果

共有 71 例患者(86.6%)被归类为 SJS,另外 11 例患者(13.4%)被归类为 TEN。药物相关病例(43 例,占 52.4%)比非药物相关病例(39 例,占 47.6%)更常见。最常见的致病药物是抗惊厥药(12/82,14.6%)和抗生素(9/82,11%)。药物相关病例中更常见贫血(p = 0.017)和 C 反应蛋白≥5mg/dL(p = 0.026)。静脉类固醇治疗是主要的治疗方案(70/82,85.4%)。82 例患者中,8 例(9.8%)在病程中死亡。单因素分析显示,肾功能异常、肺炎、血红蛋白<10g/dL 和合并基础疾病与死亡率有关。多因素分析显示,只有肺炎有统计学意义(比值比,25.79;p = 0.009)。

结论

药物是这些疾病最常见的原因。然而,非药物相关的原因也占了相当大的比例。医生在记录病史时应牢记这一点。此外,早期识别和治疗可能对更好的预后很重要。

相似文献

1
Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients.
Korean J Intern Med. 2012 Jun;27(2):203-10. doi: 10.3904/kjim.2012.27.2.203. Epub 2012 May 31.
2
Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
Burns. 2020 Jun;46(4):959-969. doi: 10.1016/j.burns.2019.10.008. Epub 2019 Dec 30.
4
Clinical manifestations and outcomes in 17 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Australas J Dermatol. 1999 Aug;40(3):131-4. doi: 10.1046/j.1440-0960.1999.00342.x.
5
6
Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective descriptive study.
Int J Dermatol. 2019 Nov;58(11):1293-1299. doi: 10.1111/ijd.14493. Epub 2019 Jun 5.

引用本文的文献

1
The Prevalence of Stevens-Johnson Syndrome Complications due to Antiepileptic Drug Use: A Systematic Review and Meta-Analysis.
Int J Prev Med. 2025 Jul 30;16:41. doi: 10.4103/ijpvm.ijpvm_132_24. eCollection 2025.
2
Liver Injury in Immune Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Five New Classification Types.
J Clin Transl Hepatol. 2025 Apr 28;13(4):339-357. doi: 10.14218/JCTH.2024.00402. Epub 2025 Jan 17.
3
Update on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management.
Am J Clin Dermatol. 2024 Nov;25(6):891-908. doi: 10.1007/s40257-024-00889-6. Epub 2024 Sep 15.
4
Stevens-Johnson Syndrome From Combined Allopurinol and Angiotensin-Converting Enzyme Inhibitors: A Narrative Review.
Cureus. 2024 Jan 8;16(1):e51899. doi: 10.7759/cureus.51899. eCollection 2024 Jan.
5
Ocular manifestations in acute stage Stevens-Johnson syndrome/toxic epidermal necrolysis - A retrospective study in a tertiary hospital in South India.
Taiwan J Ophthalmol. 2021 Jun 26;12(2):184-190. doi: 10.4103/tjo.tjo_13_21. eCollection 2022 Apr-Jun.
6
A Rare Pediatric Case of Cefixime Induced Toxic Epidermal Necrolysis.
Hosp Pharm. 2022 Apr;57(2):237-240. doi: 10.1177/00185787211016332. Epub 2021 May 20.
8
Diagnostic and Treatment Approach in the Management of Dental Anomalies Associated with Stevens-Johnson Syndrome: A Case Report.
Int J Clin Pediatr Dent. 2021 Jul-Aug;14(4):569-574. doi: 10.5005/jp-journals-10005-1986.
9
SJS/TENN: A Mnemonic for Early Clinical Diagnosis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Kans J Med. 2021 Apr 19;14(1):114-115. doi: 10.17161/kjm.vol1414842. eCollection 2021.
10
Viral Infections and Cutaneous Drug-Related Eruptions.
Front Pharmacol. 2021 Mar 10;11:586407. doi: 10.3389/fphar.2020.586407. eCollection 2020.

本文引用的文献

1
The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Expert Rev Clin Immunol. 2011 Nov;7(6):803-13; quiz 814-5. doi: 10.1586/eci.11.66.
2
Comparison of the causes and clinical features of drug rash with eosinophilia and systemic symptoms and stevens-johnson syndrome.
Allergy Asthma Immunol Res. 2010 Apr;2(2):123-6. doi: 10.4168/aair.2010.2.2.123. Epub 2010 Mar 24.
4
Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset.
Am J Ophthalmol. 2009 Jun;147(6):1004-11, 1011.e1. doi: 10.1016/j.ajo.2008.12.040. Epub 2009 Mar 14.
5
Stevens-Johnson syndrome and toxic epidermal necrolysis.
Autoimmun Rev. 2008 Sep;7(8):598-605. doi: 10.1016/j.autrev.2008.06.004. Epub 2008 Jul 9.
8
Mycoplasma pneumoniae associated with Stevens Johnson syndrome.
Anaesth Intensive Care. 2007 Jun;35(3):414-7. doi: 10.1177/0310057X0703500317.
9
Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis.
Acta Derm Venereol. 2007;87(2):144-8. doi: 10.2340/00015555-0214.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验